Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy.
about
Sequential versus standard triple therapy for Helicobacter pylori eradicationSequential versus standard triple first-line therapy forHelicobacter pylorieradicationAntibiotic treatment for Helicobacter pylori: Is the end coming?The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysisTreatment of Helicobacter pylori infection: current status and future concepts.Optimal treatment strategy for Helicobacter pylori: era of antibiotic resistance.Helicobacter pylori: the challenge in therapy.Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.Hybrid therapy for Helicobacter pylori infection: A systemic review and meta-analysis.Helicobacter pylori Eradication Therapy: Current Availabilities.Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infectionHelicobacter pylori eradication: sequential therapy and Lactobacillus reuteri supplementation.Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen.Hybrid, sequential and concomitant therapies for Helicobacter pylori eradication: A systematic review and meta-analysis.Effects of N-acetylcysteine on First-Line Sequential Therapy for Helicobacter pylori Infection: A Randomized Controlled Pilot Trial.Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind studyThe sequential therapy regimen for Helicobacter pylori eradication.Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.Review: efficacy and safety of hybrid therapy for Helicobacter pylori infection: a systematic review and meta-analysis.Systematic review and meta-analysis: full- vs. half-dose anti-microbials in clarithromycin-based regimens for Helicobacter pylori eradication.Sequential (as Opposed to Simultaneous) Antibiotic Therapy Improves Helicobacter pylori Eradication in the Pediatric Population: A Meta-Analysis.Sequential Therapy for Helicobacter Pylori Eradication: The Time is Now!Ciprofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: A randomized trial.New erythromycin derivatives enhance β-lactam antibiotics against methicillin-resistant Staphylococcus aureus.Effect of black tea aqueous non-dialysate onHelicobacter pylori infection in Mongolian gerbils.Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin.Helicobacter pylori infection in clinical practice: probiotics and a combination of probiotics + lactoferrin improve compliance, but not eradication, in sequential therapy.Efficacy of hybrid therapy as first-line regimen for Helicobacter pylori infection compared with sequential therapy.Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance.High eradication rates of Helicobacter pylori with a new sequential treatment.High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection.Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection.Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study.Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin.Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin.A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea.Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study.Comparison of the efficacy and safety of hybrid and sequential therapies as a first-line regimen for Helicobacter pylori infection in Turkey.
P2860
Q24236178-1787779B-0A67-46C1-A41C-85AE6A191B51Q26471410-54C25B3F-3810-4C03-82ED-6112826E8F12Q26777623-EB8415FD-6EE6-4B5D-B187-2F2B17F9CBABQ33287535-296CF08A-4934-4F78-AC2D-4917753A3825Q33594850-6741CE73-DA1F-4B20-A0E2-E92F46285DB3Q33626779-E9FCEA5D-2C6B-4D3D-9836-689B329E092FQ34799596-56A0F358-9E3C-4BF3-88D9-CCCA81AE02ADQ34827671-48C05366-1D98-4388-A971-A3F1CA6B54D3Q35534113-571ED0D8-5BED-4FC5-AB75-866CD6384664Q35841617-8D1A82BF-FEBC-4CB6-A80D-ACC6857280DDQ35868940-FE6F944A-D223-4E31-8ED5-77439FF545E2Q36148148-531255B5-DC5E-4E33-84D8-8B16FAC38300Q36360839-E2234D7D-ABAA-473E-A76E-3754E7F35FDBQ36410382-2CEB8B14-F536-4BEB-926E-E0A6EA51C78DQ36883328-F53B9535-7AE0-4A94-82C1-DA4827E1A4E9Q36909268-055F7079-0C53-42D6-B10A-DA8305D5BD70Q37066347-59CCA180-C995-4C7F-BF5D-3C955DFC05C3Q37282589-50B2CF6B-8A38-4CA8-8699-69FD96266CAFQ37703245-7FA88FD7-B578-45A1-94F9-CA6F75576D11Q37899929-9567084D-68BB-4614-BA05-7080501EF436Q38266303-BA5E9BE4-0269-4147-9D78-0E19C4E22F67Q38502899-8DB39BA7-4389-43FE-8422-4550274AB661Q41038984-167A8CE9-F665-4B39-87DA-D98A8A27CF70Q41173895-B55DAF48-C518-4EA7-BFC7-E79BA8507720Q41461677-52535987-6FD4-4D5B-959D-97538EC9ADE9Q41545038-CBE046E7-8539-4107-B9A9-32DAE203185CQ43074853-8E8C0ED2-BA2F-4B06-AE35-7E6129DDF03EQ44186835-07AAB796-C7BB-4031-93FA-C2F82274BC31Q44200362-6267A520-1C5E-4B3A-8EE3-99F39C462D60Q44247194-4D8AE459-AF7D-46FA-9433-95E5D6B2FE90Q44256483-015F85D4-85A0-4F48-A1D3-BE27A26D1135Q44364944-2D7DE9AC-96F4-4A54-B1D6-F26C37C7B3E8Q44505171-5E341640-CBE8-4D1D-99C1-D12527E8EB87Q44668880-1DA303C3-CF18-4D82-805D-DB5203FD8A27Q45405803-1E551688-183A-4708-B477-785DEF0ADE5BQ46967724-11A2511C-8CE3-4EE3-B6E3-106B9BEDBCE9Q47995761-1D5E3C55-0080-468B-922D-D31628AAE1EAQ51712832-7529BFFD-227F-4242-A69B-CA7B3C874642Q53406620-21B608AE-DDDD-481B-B981-03DC09FD373DQ55401337-0C23F9D2-CEF9-4A48-B1DF-9F774DD674A7
P2860
Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Drug combinations with amoxyci ...... er pylori eradication therapy.
@en
Drug combinations with amoxyci ...... er pylori eradication therapy.
@nl
type
label
Drug combinations with amoxyci ...... er pylori eradication therapy.
@en
Drug combinations with amoxyci ...... er pylori eradication therapy.
@nl
prefLabel
Drug combinations with amoxyci ...... er pylori eradication therapy.
@en
Drug combinations with amoxyci ...... er pylori eradication therapy.
@nl
P2093
P1476
Drug combinations with amoxyci ...... er pylori eradication therapy.
@en
P2093
P356
10.1016/S0924-8579(01)00456-3
P577
2002-01-01T00:00:00Z